125 results
10-K
2015 FY
EX-10.21
IBRX
ImmunityBio Inc
30 Mar 16
Annual report
12:00am
for the Company’s long-term disability benefits or (ii) in the opinion of the Company, you have been unable to carry out your responsibilities and functions … and/or penalty to you under Section 409A of the Code.
As an employee, you are also eligible to receive certain employee benefits. A summary
8-K/A
EX-99.3
IBRX
ImmunityBio Inc
22 Apr 21
Index to Immunitybio Consolidated Financial Statements
4:06pm
pandemic, or responses to the pandemic, on our business, clinical trials or personnel;
our expectations regarding the potential benefits of our strategy … and technology;
our expectations regarding the operation of our product candidates and related benefits;
our ability to utilize multiple modes
S-4
EX-10.31
IBRX
ImmunityBio Inc
19 Jan 21
Registration of securities issued in business combination transactions
5:20pm
benefits or (ii) in the reasonable opinion of the Company, you have been unable to carry out the essential responsibilities and functions of your position … to avoid the imposition of any additional taxes, interest and/or penalty under Section 409A of the Code.
Benefits: You will be eligible to participate
8-K
EX-10.1
7lp tn3xh0q
9 Mar 21
ImmunityBio and NantKwest Complete Merger
9:58pm
8-K
EX-99.1
r234213omd3gao1tg 77
10 Jun 19
Other Events
4:04pm
8-K
EX-99.2
fgligh 11qgw
10 Jun 19
Other Events
4:04pm
S-4
EX-10.11
laurlk88ijitf5d8s
19 Jan 21
Registration of securities issued in business combination transactions
5:20pm
8-K
EX-10.1
rfw2y dwf7y
7 Jun 19
Cheryl Cohen Appointed to Nantkwest’s Board of Directors
4:05pm
S-8
EX-10.1
uwvkp5 eosgu4
14 Jun 22
Registration of securities for employees
5:28pm
S-4
EX-10.12
xh03 tibnn
19 Jan 21
Registration of securities issued in business combination transactions
5:20pm
CORRESP
89n2vlzkx 7a1
15 Jul 15
Correspondence with SEC
12:00am
8-K/A
EX-99.1
e9llhlr
22 Apr 21
Index to Immunitybio Consolidated Financial Statements
4:06pm
8-K/A
EX-99.2
33i fyf4ebyabs
22 Apr 21
Index to Immunitybio Consolidated Financial Statements
4:06pm
S-4
EX-10.22
4dqyv46m1rwh6238uva
19 Jan 21
Registration of securities issued in business combination transactions
5:20pm